Actionable news
0
All posts from Actionable news
Actionable news in BLUE: bluebird bio, Inc.,

bluebird bio to Present at Four Upcoming Conferences

CAMBRIDGE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (Nasdaq: BLUE), a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic diseases and T cell-based immunotherapies for cancer, today announced that members of the management team will present at the following upcoming investor conferences:

  • Citi 11th Annual Biotech Conference on September 7, 2016. Panel discussion at 1:00 p.m. ET at the Mandarin Oriental Hotel in Boston.
  • Wells Fargo Securities Healthcare Conference, on September 8, 2016, 9:20 a.m. ET at the Westin Waterfront in Boston.
  • Morgan Stanley Global Healthcare Conference on September 13, 2016, 4:05 p.m. ET at the Grand Hyatt in New York.
  • LEERINK Partners Roundtable Series: Rare Disease & Immuno-Oncology on September 29, 2016 at 2:00 p.m. ET at the Lotte New York Palace in New York.

To access the live webcast of bluebird bio’s presentations, please visit the “Events & Presentations” page within the Investors and Media section of the bluebird bio website at http://investor.bluebirdbio.com. Replays of the webcasts will be available on the bluebird bio website for 90 days following the conferences.

About bluebird bio, Inc.

With its lentiviral-based gene therapies, T cell immunotherapy expertise and gene editing capabilities, bluebird bio has built an integrated product platform with broad...


More